Hyperthermia Treatment For Cancer Market: Segment Snapshot and Table of Content (2017-2025)

The increasing number of cancer patient worldwide is translating into higher demand for cancer therapies. Governments in various countries have launched promotional campaigns to aware people about getting the right cancer treatment. To an extent, these aforementioned factors are helping popularize various cancer therapeutics including hyperthermia treatment for cancer. Moreover, medical institutes are working in collaboration with the government for cancer research to further improve diagnosis and treatment. Clinical trials are also funded by governments to support companies in developing effective hyperthermia treatment for cancer. Persistence Market Research (PMR) in its latest report titled “Hyperthermia Treatment for Cancer Market: Global Industry Analysis and Forecast, 2017–2025” projects that global hyperthermia treatment for cancer market revenue will surge at a CAGR of 6.1% during the forecast period (2017–2025).

PMR in its report has profiled some of the prominent players operating in the global market for hyperthermia treatment for cancer, which includes Andromedic Srl, Celsius42 GmbH, Haifu Medical Technology Co. Ltd., Hydrosun GmbH, Pyrexar Medical Inc., Yamamoto Vinita Co., Ltd, and Oncothermia. These companies are actively focusing towards launching technologically advanced products and also further develop distribution networks in order to strengthen their market position.

Get Full Report@ https://www.persistencemarketresearch.com/market-research/hyperthermia-treatment-for-cancer-market.asp

The global Hyperthermia Treatment For Cancer Market is segmented on the basis of device type, application, end user and region.

By device type, the microwave hyperthermia device segment is estimated to account for 41.4% revenue share of the market by 2017-end. The segment is expected to further gain traction, owing to its ability to transmit energy from antenna to cancer cells without getting stuck in fat layers. Meanwhile, short-wave hyperthermia device segment is expected to witness the fastest CAGR of 7.0% during the forecast period.

Based on application, breast cancer and leukemia segments collectively accounted for 45% of the total market in 2016 and is expected to remain as the two dominant application segments of the market in 2017 and beyond.

By end use, the hospitals end user segment accounted for more than 42% share of the market. This is primarily owing to the growing ration of cancer patients in hospitals.

Among regions, the market for hyperthermia treatment for cancer in North America is expected to remain dominant throughout the forecast. In 2016, the region’s market reached a valuation of US$ 39.4 Mn and anticipated to grow at a CAGR of 5.5% over the projection period. This is majorly attributed to the presence of leading medical companies and healthcare organizations in the region. Meanwhile, the market in Asia-Pacific is set to witness the fastest CAGR of 7.2%. By the 2017-end, the region is projected to account for 10.0% revenue share of the market.

Request A Sample Report @ https://www.persistencemarketresearch.com/samples/14632

Summary of Table of Content

1. Executive Summary
2. Market Introduction
3. Global Hyperthermia Treatment for Cancer Market Analysis Scenario
4. Market Dynamics
5. Global Hyperthermia Treatment for Cancer Market Analysis and Forecasts, By Devices Type
6. Global Hyperthermia Treatment for Cancer Market Analysis and Forecasts, By End User
7. Global Hyperthermia Treatment for Cancer Market Analysis and Forecasts, By Application
8. Global Hyperthermia Treatment for Cancer Market Analysis and Forecasts, By Region
9. North America Hyperthermia Treatment for Cancer Market Analysis and Forecast
10. Europe Hyperthermia Treatment for Cancer Market Analysis and Forecast
11. Latin America Hyperthermia Treatment for Cancer Market Analysis and Forecast
12. Asia Pacific Hyperthermia Treatment for Cancer Market Analysis and Forecast
13. Middle East & Africa Hyperthermia Treatment for Cancer Market Analysis and Forecast
14. Competition Landscape
15. Assumptions and Acronyms Used
16. Research Methodology

Request to Browse Full Table of Content, figure and Tables @ https://www.persistencemarketresearch.com/market-research/hyperthermia-treatment-for-cancer-market/toc

About Us

Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.

Contact Us

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

This release was published on openPR.